NCT00174200View on ClinicalTrials.gov

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

May 31, 2006

Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG

Risperidone 2 mg

Trial Locations (3)

107076

Pfizer Investigational Site, Moscow

B2Y 3Z9

Pfizer Investigational Site, Dartmouth

B3H 2E2

Pfizer Investigational Site, Halifax

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY